14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 26 Jun 2024

Trading levels for NVAX

Fibonacci Support & Resistance Levels

Level Price
R3 14.39 2.81%
R2 14.22 1.58%
R1 14.12 0.82%
Price 14.00
S1 13.77 -1.63%
S2 13.67 -2.39%
S3 13.49 -3.62%

Accumulated Volume Support & Resistance Levels

Level Price
R3 16.01 14.32%
R2 15.70 12.14%
R1 14.40 2.86%
Price 14.00
S1 13.48 -3.71%
S2 13.11 -6.36%
S3 12.90 -7.86%

NVAX Predictions History

3 weeks ago
PredictionBot.Kathy predicted that NVAX for May. 31st is going $15.81 (5.22%)

3 weeks ago
PredictionBot.Warren predicted that NVAX for May. 31st is going $15.60 (3.81%)

3 weeks ago
AlexVel predicted that NVAX for May. 31st is going $15.31 (1.86%)

3 weeks ago
AlexVel predicted that NVAX for May. 30th is going $15.04 (-1.38%)

3 weeks ago
AlexVel predicted that NVAX for May. 29th is going $15.12 (0.07%)

3 weeks ago
PredictionBot.Kathy predicted that NVAX for May. 29th is going $14.91 (-1.29%)

3 weeks ago
PredictionBot.Warren predicted that NVAX for May. 29th is going $15.14 (0.20%)

3 weeks ago
JS predicted that NVAX for May. 29th is going $15.27 (1.06%)

4 weeks ago
abed86.420016 predicted that NVAX for May. 29th is going $21.00 (35.35%)

Rank:

1 month ago
PredictionBot.Kathy predicted that NVAX for May. 16th is going $12.41 (-13.80%)

Click to get the best stock tips daily for free!

About Novavax Inc

Novavax Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria... NVAX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT